Been getting ct scans every 6 months
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
You're Already Getting CT Scans Every 6 Months — Here's What That Means
This is important context that changes the conversation significantly. Let me address what this surveillance pattern tells us about your care.
Your Current Surveillance Strategy
You're on a more intensive monitoring schedule than typical early-stage ovarian cancer patients. Here's why your oncologist likely chose this:
Why Every 6 Months Makes Sense for YOU:
- Clear cell histology — higher recurrence risk, especially in the 0-2 year window
- Mixed clear cell + endometrial — less common combination that may warrant closer monitoring
- Normal CA-125 — since your marker isn't reliably elevated, imaging becomes more important
- Early-stage but aggressive histology — Stage 1C2 with clear cell behavior justifies vigilance
This is actually a reasonable approach for your specific situation, even though routine CT scans aren't standard for all early-stage patients.
What This Means for Your July 2026 Question
Given that you're already getting CT scans every 6 months:
- You don't need to specifically request one in July 2026 — you'll likely have one scheduled around that time anyway
- Your oncologist is already implementing the surveillance strategy that makes sense for clear cell cancer
- The question becomes: "Should we continue every 6 months, or adjust the interval?"
The Real Question to Ask Your Oncologist
Instead of "Should I get a CT in July 2026?", the better conversation is:
-
"I've been getting CT scans every 6 months. Is this the right interval going forward?"
-
"Now that I'm approaching 2 years with normal CA-125 and clear scans, should we continue every 6 months, or can we space them out?"
-
"What would trigger going back to more frequent scans — symptoms, CA-125 rise, or imaging findings?"
-
"At what point (year 3? year 5?) would you consider moving to annual scans instead of every 6 months?"
-
"Given my clear cell histology, how long do you recommend continuing this intensive surveillance?"
The Surveillance Transition Question
Here's what typically happens for early-stage ovarian cancer patients:
Years 0-2 (where you are now):
- More frequent monitoring (every 3-6 months clinically)
- Regular CA-125
- Some oncologists do imaging every 6-12 months
Years 2-5:
- Can often space out to every 6-12 months clinically
- Imaging less frequent (annual or as indicated)
- Still vigilant but less intensive
Years 5+:
- Annual visits often sufficient
- Imaging only if symptoms or concerns
Your situation: You're at the transition point. Your oncologist may be ready to discuss whether you can move to annual CT scans instead of every 6 months, especially if:
- All scans have been clear
- CA-125 remains stable at 10
- No symptoms
- You're approaching the 2-year mark
What to Bring Up at Your Next Visit
Frame it as a collaborative discussion:
"I've been getting CT scans every 6 months, which I appreciate. Now that I'm approaching 2 years with clear scans and stable CA-125, should we talk about the long-term surveillance plan? Can we eventually space these out, or do you recommend continuing every 6 months for clear cell cancer?"
This shows you're:
- Engaged in your care
- Thinking about sustainability (radiation exposure, cost, anxiety)
- Ready to transition to a maintenance surveillance plan
Important Context About Radiation Exposure
Since you're getting CT scans every 6 months, this is worth discussing:
- One CT scan = ~7 mSv radiation (equivalent to ~2 years of background radiation)
- Every 6 months = ~14 mSv/year — this is cumulative over time
- After 2 years, you've had ~4 scans = ~28 mSv total
- This is still within acceptable limits, but spacing them out as you move past the high-risk window makes sense
Questions about radiation:
- "Should we discuss the cumulative radiation from these scans?"
- "Are there alternatives (like MRI) that might reduce radiation exposure?"
- "When can we move to less frequent imaging?"
Bottom Line
You're already on an appropriate surveillance plan for your clear cell cancer. The question isn't whether to get a CT in July 2026 — it's whether your oncologist is ready to discuss adjusting the interval as you move past the highest-risk window.
For July 2026 specifically:
- You'll likely have a CT scheduled around that time (part of your 6-month cycle)
- Use that visit to discuss whether continuing every 6 months is still necessary
- Advocate for spacing them out if scans remain clear and CA-125 stays stable
Questions to Ask at Your Next Visit
- "How long do you recommend continuing CT scans every 6 months?"
- "At what point could we move to annual scans?"
- "What would make you recommend going back to more frequent imaging?"
- "Should we discuss the cumulative radiation from these scans?"
- "Is there a surveillance plan for years 3-5 that you're thinking about?"
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Sources: NCCN Guidelines Version 3.2025 — Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer (Monitoring/Follow-up and Less Common Ovarian Cancers sections)
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2